Pluri Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Flagged at $1.23 at 09:41 AM on Oct 28, then ran to $1.43 +16% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is PLUR down today? It is at $1.23 (-3.15%), and our scanner flagged it 9 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PLUR spikes, and full due diligence on PLUR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PLUR 9 times in the last 30 days. Create a free account to track $PLUR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PLUR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PLUR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystMaterial Agreement · Unregistered Share Sale, from the latest SEC filing. Read it →Across every filing on file, supply equal to at least 145.7% of the tradeable float is in play - 145.7% more can still be issued.
Some filings did not state a size, so these are floors.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
11,436,075 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $10.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Manieu Alexandre Weinstein Director | Bought (open market) | +833K 6.6% of company | added 67% | 2.08M | $1.3M at $1.50 | Oct 23, 26 |
Manieu Alexandre Weinstein Director | Other | 641 | added 9.3% | 8K | n/a | Aug 25, 26 |
Manieu Alexandre Weinstein Director | Acquired (grant/award) | +180K 1.4% of company | added 100% | 191K | n/a | Aug 20, 26 |
Shorrer Doron Director | Acquired (grant/award) | +32K 0.3% of company | added 100% | 38K | n/a | Aug 20, 26 |
Manieu Alexandre Weinstein Director | Acquired (grant/award) | +641 | added 10% | 7K | n/a | Jun 30, 26 |
Manieu Alexandre Weinstein Director | Acquired (grant/award) | +313K 2.5% of company | added 15% | 2.39M | $625K at $2.00 | Apr 21, 26 |
Manieu Alexandre Weinstein Director | Acquired (grant/award) | +313K 2.5% of company | added 50% | 938K | $625K at $2.00 | Mar 31, 26 |
Manieu Alexandre Weinstein Director | Acquired (grant/award) | +625K 5.0% of company | added 100% | 1.08M | $1.3M at $2.00 | Dec 8, 25 |
Aberman Zami Director | Acquired (grant/award) | +346 | added 0.2% | 144K | n/a | Dec 4, 25 |
Shemesh-Rasmussen Maital Director | Acquired (grant/award) | +699 | added 3.8% | 19K | n/a | Dec 4, 25 |
Zalts Liat Officer | Acquired (grant/award) | +4K 0.03% of company | added 4.1% | 93K | n/a | Dec 4, 25 |
Levi Rami Avraham Director | Acquired (grant/award) | +653 | added 3.6% | 19K | n/a | Dec 4, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on PLUR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PLUR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
PLUR last traded at $1.23, down 3.15% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Pluri Inc. Common Stock (PLUR) is next expected to report earnings on Wednesday, November 11, 2026, about 7 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PLUR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PLUR 9 times in the last 30 days.
PLUR (Pluri Inc. Common Stock) trades on XNAS, with a market cap of about $16M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PLUR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PLUR discussion
Sign in to ask a question or join the discussion.